Acupoint Stimulation Improves Postoperative Wound Pain
Acupoint Stimulation Intervention Improves Postoperative Wound Pain and Mobility in Patients With Abdominal Surgery
1 other identifier
interventional
72
1 country
1
Brief Summary
Postoperative pain remains one of the most common and distressing symptoms experienced by surgical patients. Poorly managed postoperative pain can impede recovery, reduce patient willingness to mobilize, increase the risk of complications, and negatively affect overall quality of life. Currently, opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) are the primary pharmacological strategies for managing postoperative pain. However, these medications often carry the risk of adverse effects and may not adequately address all aspects of patient comfort and recovery. In response to this challenge, this study aims to evaluate the effects of a non-pharmacological, non-invasive intervention-acupoint stimulation-on postoperative wound pain and mobilization in patients undergoing abdominal surgery. Ultimately, this study seeks to contribute to the development of more diversified and patient-centered pain management strategies, with the expectation that the integration of Chinese and Western medicine will lead to improved patient care and enhanced postoperative recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 19, 2024
CompletedFirst Submitted
Initial submission to the registry
May 11, 2025
CompletedFirst Posted
Study publicly available on registry
May 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 28, 2025
May 1, 2025
1.3 years
May 11, 2025
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Intensity Measured by Visual Analog Scale (VAS)
Pain intensity will be assessed using the Visual Analog Scale (VAS). The primary analysis will focus on changes in pain intensity over time between the two groups.
At 1, 4, 12, 24, 48, and 72 hours post-surgery
Secondary Outcomes (1)
Pain Impact Assessed by Brief Pain Inventory - Taiwan Version (BPI-Taiwan)
On postoperative Day 3
Other Outcomes (2)
Total Analgesic Consumption Within 72 Hours After Surgery
Within 72 hours after surgery
Time to First Ambulation After Surgery
Within 72 hours after surgery
Study Arms (2)
Experimental: Acupoint Stimulation
EXPERIMENTALAcupoint stimulation was administered on six points and auricular points on three points on the left ear, additional auricular points were selected according to the abdominal organ involved in surgery and its corresponding meridian representation on the auricle.
Control: Sham Acupoint Stimulation
SHAM COMPARATORInterventions
This intervention involves acupoint stimulation and auricular acupressure. Stimulation of selected body acupoints is administered by trained personnel following a standardized protocol. The intervention is provided once daily for three consecutive days, beginning post-surgery. For auricular acupressure, additional auricular points are chosen based on the involved abdominal organ and its corresponding viscera-meridian locations on the auricle. Vaccaria seeds are applied to the selected points with adhesive patches, and patients are instructed to apply pressure to the points regularly throughout the day.
Participants in this group will receive a sham acupoint stimulation procedure. Acupoint stimulation will be using identical procedures to the experimental group, without applying pressure. No stimulation or manipulation was performed. The frequency and timing of the sham intervention matched that of the experimental group.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Surgical wound length ≥ 10 cm
- American Society of Anesthesiologists (ASA) physical status classification I to III
- Receiving intravenous patient-controlled analgesia (IV PCA)
- Clear consciousness and ability to communicate
- Willingness to participate and provide informed consent
You may not qualify if:
- Presence of arrhythmia
- Implanted artificial cardiac pacemaker
- Cutaneous lesions at the acupoint or auricular application sites
- History of chronic pain or abdominal surgery within the past 6 months
- Non-ambulatory status prior to surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cheng Hsin General Hospital
Taipei, Peitou Dist, 112, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2025
First Posted
May 18, 2025
Study Start
June 19, 2024
Primary Completion
September 30, 2025
Study Completion
December 31, 2025
Last Updated
May 28, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share